A nurse is caring for a client who has urinary leakage due to nerve damage following a spinal cord injury. The nurse should identify that the client is experiencing which of the following types of urinary incontinence?

Choice A reason: Impaired sense of humor is not a common finding for a client who had a stroke involving the left cerebral hemisphere. Impaired sense of humor is more likely to occur after a stroke involving the right cerebral hemisphere, which is responsible for processing humor, irony, and sarcasm.

Choice B reason: Poor judgment is not a typical finding for a client who had a stroke involving the left cerebral hemisphere. Poor judgment is more likely to occur after a stroke involving the frontal lobe, which is involved in executive functions, such as planning, reasoning, and decision making.

Choice C reason: Intellectual impairment is a possible finding for a client who had a stroke involving the left cerebral hemisphere. The left cerebral hemisphere is dominant for language and analytical thinking in most people. A stroke affecting this hemisphere can impair the ability to speak, read, write, calculate, and comprehend information.

Choice D reason: Loss of depth perception is not a frequent finding for a client who had a stroke involving the left cerebral hemisphere. Loss of depth perception is more likely to occur after a stroke involving the occipital lobe, which is involved in visual processing, or the parietal lobe, which is involved in spatial awareness.

Choice A reason: Blood glucose levels are not a necessary laboratory test for a client who has tuberculosis and new prescriptions for rifampin and pyrazinamide. Blood glucose levels measure the amount of sugar in the blood and are used to diagnose and monitor diabetes. Rifampin and pyrazinamide do not affect blood glucose levels directly, but they may interact with some medications used to treat diabetes, such as sulfonylureas or metformin. The nurse should advise the client to monitor their blood glucose levels regularly and report any changes to the provider.

Choice B reason: Thyroid function studies are not a required laboratory test for a client who has tuberculosis and new prescriptions for rifampin and pyrazinamide. Thyroid function studies measure the levels of thyroid hormones and thyroid stimulating hormone in the blood and are used to diagnose and monitor thyroid disorders. Rifampin and pyrazinamide do not affect thyroid function directly, but they may interact with some medications used to treat thyroid disorders, such as levothyroxine or propylthiouracil. The nurse should advise the client to take their thyroid medication at least 4 hours before or after rifampin and pyrazinamide and report any symptoms of thyroid imbalance to the provider.

Choice C reason: Gallbladder studies are not a relevant laboratory test for a client who has tuberculosis and new prescriptions for rifampin and pyrazinamide. Gallbladder studies include ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) scans of the gallbladder and are used to diagnose and monitor gallstones or gallbladder inflammation. Rifampin and pyrazinamide do not affect the gallbladder directly, but they may cause side effects such as nausea, vomiting, or abdominal pain, which can mimic gallbladder problems. The nurse should assess the client for signs of hepatotoxicity, such as jaundice, dark urine, or clay colored stools, and report any findings to the provider.

Choice D reason: Liver function tests are a vital laboratory test for a client who has tuberculosis and new prescriptions for rifampin and pyrazinamide. Liver function tests measure the levels of enzymes, proteins, and bilirubin in the blood and are used to diagnose and monitor liver damage or disease. Rifampin and pyrazinamide are both hepatotoxic drugs, which means they can cause liver injury or failure. The nurse should instruct the client to have liver function tests done before starting the medication regimen and periodically during the treatment. The nurse should also educate the client about the signs and symptoms of hepatotoxicity, such as fatigue, loss of appetite, nausea, vomiting, or yellowing of the skin or eyes, and advise them to stop taking the medication and seek medical attention if they occur.